SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-23-013900
Filing Date
2023-04-28
Accepted
2023-04-27 18:00:30
Documents
75

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 2669886
2 ex23-2.htm EX-23.2 3806
3 ex107.htm EX-FILING FEES 82385
4 forms-1_001.jpg GRAPHIC 17137
  Complete submission text file 0001493152-23-013900.txt   9213544

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ensc-20221231.xsd EX-101.SCH 55756
6 XBRL CALCULATION FILE ensc-20221231_cal.xml EX-101.CAL 74986
7 XBRL DEFINITION FILE ensc-20221231_def.xml EX-101.DEF 301180
8 XBRL LABEL FILE ensc-20221231_lab.xml EX-101.LAB 511549
9 XBRL PRESENTATION FILE ensc-20221231_pre.xml EX-101.PRE 413570
69 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 1146987
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-271480 | Film No.: 23858882
SIC: 2834 Pharmaceutical Preparations